$VRME
VerifyMe Inc Stock $vrme

$vrme Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000121465922010219 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$5.215M	$4.497M	$161.0K
YoY Change	1638.33%	3526.61%	-15.26%
Cost Of Revenue	$3.360M	$2.812M	$38.00K
YoY Change	2847.37%	10715.38%	-5.0%
Gross Profit	$1.855M	$1.685M	$123.0K
YoY Change	897.31%	1619.39%	-18.0%
Gross Profit Margin	35.57%	37.47%	76.4%
Selling, General & Admin	$2.691M	$2.982M	$1.764M
YoY Change	187.81%	96.96%	30.18%
% of Gross Profit	145.07%	176.97%	1434.15%
Research & Development	$39.00K	$25.00K	$9.000K
YoY Change	387.5%	108.33%	-10.0%
% of Gross Profit	2.1%	1.48%	7.32%
Depreciation & Amortization	$261.0K	$243.0K	$35.00K
YoY Change	800.0%	594.29%	75.0%
% of Gross Profit	14.07%	14.42%	28.46%
Operating Expenses	$2.730M	$3.007M	$1.764M
YoY Change	191.98%	97.05%	30.18%
Operating Profit	-$875.0K	-$1.322M	-$1.641M
YoY Change	16.82%	-7.42%	36.18%
Interest Expense	-$33.00K	-$11.23M	$253.0K
YoY Change	-100.4%
% of Operating Profit
Other Income/Expense, Net	$318.0K	-$11.23M	$3.000K
YoY Change	-96.13%	-16147.14%
Pretax Income	-$557.0K	-$12.56M	-$1.394M
YoY Change	-107.75%	824.52%	14.26%
Income Tax
% Of Pretax Income
Net Earnings	-$557.0K	-$12.56M	-$1.394M
YoY Change	-107.75%	824.52%	14.26%
Net Earnings / Revenue	-10.68%	-279.19%	-865.84%
Basic Earnings Per Share	-$0.06	-$1.53	-$0.19
Diluted Earnings Per Share	-$0.06	-$1.53	-$194.2K
COMMON SHARES
Basic Shares Outstanding	8.467M shares	8.219M shares	7.179M shares
Diluted Shares Outstanding	8.944M shares	8.219M shares	7.179M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.787M	$3.845M	$8.576M
YoY Change	-64.37%	-66.16%	-44.13%
Cash & Equivalents	$3.694M	$3.751M	$8.433M
Short-Term Investments	$93.00K	$94.00K	$143.0K
Other Short-Term Assets	$190.0K	$234.0K	$250.0K
YoY Change	71.17%	95.0%	0.0%
Inventory	$141.0K	$59.00K	$78.00K
Prepaid Expenses		$234.0K
Receivables	$1.188M	$1.738M	$150.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.001M	$6.498M	$9.054M
YoY Change	-45.98%	-55.59%	-42.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$321.0K	$351.0K	$188.0K
YoY Change	49.3%	680.0%	-18.26%
Goodwill	$4.092M	$4.092M
YoY Change
Intangibles
YoY Change
Long-Term Investments			$11.16M
YoY Change
Other Assets	$87.00K	$106.0K
YoY Change
Total Long-Term Assets	$11.42M	$11.60M	$11.86M
YoY Change	-0.62%	1540.31%	1644.71%
TOTAL ASSETS
Total Short-Term Assets	$6.001M	$6.498M	$9.054M
Total Long-Term Assets	$11.42M	$11.60M	$11.86M
Total Assets	$17.42M	$18.10M	$20.92M
YoY Change	-22.91%	17.97%	26.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.220M	$1.406M	$609.0K
YoY Change	181.11%	232.39%	41.63%
Accrued Expenses	$486.0K	$567.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$500.0K	$500.0K	$0.00
YoY Change
Long-Term Debt Due	$500.0K	$500.0K
YoY Change
Total Short-Term Liabilities	$2.322M	$2.589M	$609.0K
YoY Change	435.02%	512.06%	41.63%
LONG-TERM LIABILITIES
Long-Term Debt	$1.500M	$1.500M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$387.0K	$416.0K	$126.0K
YoY Change	4200.0%
Total Long-Term Liabilities	$1.887M	$1.916M	$126.0K
YoY Change	20866.67%		80.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.322M	$2.589M	$609.0K
Total Long-Term Liabilities	$1.887M	$1.916M	$126.0K
Total Liabilities	$4.209M	$4.505M	$735.0K
YoY Change	850.11%	965.01%	44.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$78.57M	-$78.01M
YoY Change		11.05%
Common Stock	$10.00K	$9.000K
YoY Change		28.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$843.0K	$756.0K
YoY Change		121.7%
Treasury Stock Shares	305.6K shares	199.0K shares
Shareholders Equity	$13.21M	$13.59M	$20.18M
YoY Change
Total Liabilities & Shareholders Equity	$17.42M	$18.10M	$20.92M
YoY Change	-22.91%	17.97%	26.85%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$557.0K	-$12.56M	-$1.394M
YoY Change	-107.75%	824.52%	14.26%
Depreciation, Depletion And Amortization	$261.0K	$243.0K	$35.00K
YoY Change	800.0%	594.29%	75.0%
Cash From Operating Activities	-$43.00K	-$1.624M	-$1.001M
YoY Change	-93.86%	111.46%	11.22%
INVESTING ACTIVITIES
Capital Expenditures	-$135.0K	-$1.000K	-$24.00K
YoY Change	575.0%	-50.0%	-81.54%
Acquisitions
YoY Change
Other Investing Activities	$19.00K	-$7.606M	$0.00
YoY Change	-94.65%	154.13%
Cash From Investing Activities	-$116.0K	-$7.607M	-$24.00K
YoY Change	-134.63%	153.99%	-81.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	102.0K	4.549M	36.00K
YoY Change	-127.79%	-2044.02%	-99.57%
NET CHANGE
Cash From Operating Activities	-43.00K	-1.624M	-1.001M
Cash From Investing Activities	-116.0K	-7.607M	-24.00K
Cash From Financing Activities	102.0K	4.549M	36.00K
Net Change In Cash	-57.00K	-4.682M	-989.0K
YoY Change	-92.21%	17.14%	-113.33%
FREE CASH FLOW
Cash From Operating Activities	-$43.00K	-$1.624M	-$1.001M
Capital Expenditures	-$135.0K	-$1.000K	-$24.00K
Free Cash Flow	$92.00K	-$1.623M	-$977.0K
YoY Change	-113.53%	111.88%	26.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1217000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4000000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001104038
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021Q4	vrme	Unbilled Revenue UnbilledRevenue		usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments		usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Goodwill Goodwill		usd
CY2021Q4	us-gaap	Other Assets OtherAssets		usd
CY2021Q4	vrme	Current Portion Of Debt CurrentPortionOfDebt		usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2021Q4	vrme	Longterm Portion Of Debt LongtermPortionOfDebt		usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2022Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet		usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet		usd
CY2021Q2	vrme	Income Loss From Equity Method Investments1 IncomeLossFromEquityMethodInvestments1		usd
	vrme	Income Loss From Equity Method Investments1 IncomeLossFromEquityMethodInvestments1		usd
CY2022Q2	us-gaap	Other Income OtherIncome		usd
CY2021Q2	us-gaap	Other Income OtherIncome		usd
	us-gaap	Other Income OtherIncome		usd
CY2022Q2	vrme	Conversion Gains And Losses On Foreign Investments1 ConversionGainsAndLossesOnForeignInvestments1		usd
	vrme	Conversion Gains And Losses On Foreign Investments1 ConversionGainsAndLossesOnForeignInvestments1		usd
	vrme	Allowance For Loan And Lease Loss Recovery Of Bad Debts1 AllowanceForLoanAndLeaseLossRecoveryOfBadDebts1		usd
	vrme	Fair Value Of Options Issued In Exchange For Services FairValueOfOptionsIssuedInExchangeForServices		usd
	us-gaap	Conversion Gains And Losses On Foreign Investments ConversionGainsAndLossesOnForeignInvestments		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	vrme	Oprating Unbilled Revenue OpratingUnbilledRevenue		usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		usd
	vrme	Due From Related Parties Deposit And Reimbursable Expenses On Investment DueFromRelatedPartiesDepositAndReimbursableExpensesOnInvestment		usd
	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease		usd
	vrme	Purchase Of Equity Investment PurchaseOfEquityInvestment		usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
	vrme	Deferred Implementation Costs DeferredImplementationCosts		usd
	us-gaap	Payments For Software PaymentsForSoftware		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans		usd
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity		usd
	vrme	Taxwithholdingpaymentsforemployeestockbasedcompensationinexchangeforsharessurrendered Taxwithholdingpaymentsforemployeestockbasedcompensationinexchangeforsharessurrendered		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	vrme	Initial Recognition Of Rightofuse Asset And Lease Liability During Period InitialRecognitionOfRightofuseAssetAndLeaseLiabilityDuringPeriod		usd
CY2021Q4	vrme	Book Value BookValue		usd
CY2022Q2	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	274000	usd
	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	477000	usd
CY2021Q2	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	149000	usd
	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	277000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	571000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	92000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y4M24D
	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms	P2Y7M6D
CY2022Q2	vrme	Sharebased Compensation Arrangement By Sharebased Payment Award Other Than Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1		usd
CY2022Q2	vrme	Property Plant And Equipment Estimated Useful Lives1 PropertyPlantAndEquipmentEstimatedUsefulLives1	P15Y
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	10011000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	10964000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2021Q4	vrme	Total Operating Lease Liabilities TotalOperatingLeaseLiabilities		usd
CY2021Q4	vrme	Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities		usd
CY2021Q4	vrme	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities		usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M18D
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39332
	dei	Entity Registrant Name EntityRegistrantName	VERIFYME, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-3023677
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Clinton Square, 75 S. Clinton Ave
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 510
	dei	Entity Address City Or Town EntityAddressCityOrTown	Rochester
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14604
	dei	City Area Code CityAreaCode	(585)
	dei	Local Phone Number LocalPhoneNumber	736-9400
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8467046	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3751000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9422000	usd
CY2022Q2	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	13000	usd
CY2021Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	0	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1738000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	297000	usd
CY2022Q2	vrme	Unbilled Revenue UnbilledRevenue	622000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	234000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	152000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	94000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	88000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	59000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	52000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	6498000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	351000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	204000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	531000	usd
CY2022Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	6517000	usd
CY2021Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	509000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	4092000	usd
CY2022Q2	us-gaap	Other Assets OtherAssets	106000	usd
CY2022Q2	us-gaap	Assets Assets	18095000	usd
CY2021Q4	us-gaap	Assets Assets	21688000	usd
CY2022Q2	vrme	Current Portion Of Debt CurrentPortionOfDebt	500000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1406000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	341000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	567000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	109000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	116000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2589000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	450000	usd
CY2022Q2	vrme	Longterm Portion Of Debt LongtermPortionOfDebt	1500000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	416000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	71000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	4505000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	521000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8666002	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7420633	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8467046	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7196677	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	92347000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	86059000	usd
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	198956	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	223956	shares
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	756000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	838000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78010000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64061000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13590000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21167000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18095000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21688000	usd
CY2022Q2	us-gaap	Revenues Revenues	4497000	usd
CY2021Q2	us-gaap	Revenues Revenues	124000	usd
	us-gaap	Revenues Revenues	4658000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7699324	shares
	us-gaap	Revenues Revenues	312000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	2812000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	26000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2850000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	69000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1685000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	98000	usd
	us-gaap	Gross Profit GrossProfit	1808000	usd
	us-gaap	Gross Profit GrossProfit	243000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2325000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17000	usd
CY2022Q2	vrme	Selling And Marketing Expense1 SellingAndMarketingExpense1	447000	usd
CY2021Q2	vrme	Selling And Marketing Expense1 SellingAndMarketingExpense1	297000	usd
	vrme	Selling And Marketing Expense1 SellingAndMarketingExpense1	746000	usd
	vrme	Selling And Marketing Expense1 SellingAndMarketingExpense1	544000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	3007000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1526000	usd
	us-gaap	Operating Expenses OperatingExpenses	4780000	usd
	us-gaap	Operating Expenses OperatingExpenses	2886000	usd
CY2022Q2	vrme	Operating Income Loss1 OperatingIncomeLoss1	-1322000	usd
CY2021Q2	vrme	Operating Income Loss1 OperatingIncomeLoss1	-1428000	usd
	vrme	Operating Income Loss1 OperatingIncomeLoss1	-2972000	usd
	vrme	Operating Income Loss1 OperatingIncomeLoss1	-2643000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-23000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-22000	usd
CY2022Q2	vrme	Income Loss From Equity Method Investments1 IncomeLossFromEquityMethodInvestments1	-11210000	usd
	vrme	Income Loss From Equity Method Investments1 IncomeLossFromEquityMethodInvestments1	-10958000	usd
	us-gaap	Other Income OtherIncome	3000	usd
CY2021Q2	vrme	Conversion Gains And Losses On Foreign Investments1 ConversionGainsAndLossesOnForeignInvestments1	70000	usd
	vrme	Conversion Gains And Losses On Foreign Investments1 ConversionGainsAndLossesOnForeignInvestments1	70000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11233000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	70000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10977000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	70000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-12555000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1358000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13949000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2573000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.53
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.81
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.53
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.81
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8218964	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7391864	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6991690	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8218964	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7391864	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7699324	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6991690	shares
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	312000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	741000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	569000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1007000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13949000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2573000	usd
	vrme	Allowance For Loan And Lease Loss Recovery Of Bad Debts1 AllowanceForLoanAndLeaseLossRecoveryOfBadDebts1	13000	usd
	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	92000	usd
	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	23000	usd
	vrme	Fair Value Of Options Issued In Exchange For Services FairValueOfOptionsIssuedInExchangeForServices	85000	usd
	vrme	Fair Value Of Restricted Stock Issued For Services FairValueOfRestrictedStockIssuedForServices	173000	usd
	vrme	Fair Value Of Restricted Stock Issued For Services FairValueOfRestrictedStockIssuedForServices	565000	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	477000	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	277000	usd
	us-gaap	Conversion Gains And Losses On Foreign Investments ConversionGainsAndLossesOnForeignInvestments	70000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-10958000	usd
	vrme	Amortization And Depreciation Or Credit AmortizationAndDepreciationOrCredit	243000	usd
	vrme	Amortization And Depreciation Or Credit AmortizationAndDepreciationOrCredit	55000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	619000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	112000	usd
	vrme	Oprating Unbilled Revenue OpratingUnbilledRevenue	-622000	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-15000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	77000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-57000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	693000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	39000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2625000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1668000	usd
	vrme	Due From Related Parties Deposit And Reimbursable Expenses On Investment DueFromRelatedPartiesDepositAndReimbursableExpensesOnInvestment	2937000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	25000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	55000	usd
	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease	45000	usd
	vrme	Purchase Of Equity Investment PurchaseOfEquityInvestment	11000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	7500000	usd
	vrme	Deferred Implementation Costs DeferredImplementationCosts	106000	usd
	us-gaap	Payments For Software PaymentsForSoftware	77000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7631000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3125000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4552000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	8447000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	67000	usd
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	228000	usd
	vrme	Taxwithholdingpaymentsforemployeestockbasedcompensationinexchangeforsharessurrendered Taxwithholdingpaymentsforemployeestockbasedcompensationinexchangeforsharessurrendered	34000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4585000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8216000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5671000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3423000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9422000	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7939000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3751000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11362000	usd
	vrme	Initial Recognition Of Rightofuse Asset And Lease Liability During Period InitialRecognitionOfRightofuseAssetAndLeaseLiabilityDuringPeriod	552000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	15989000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	350000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	149000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	13000	usd
CY2021Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	228000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1358000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	14915000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	20183000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	31000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	274000	usd
CY2022Q2	vrme	Stock Purchase Plan1 StockPurchasePlan1	35000	usd
CY2022Q2	vrme	Common Stock Issued In Relation To Private Placement CommonStockIssuedInRelationToPrivatePlacement	4552000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	96000	usd
CY2022Q2	vrme	Common Stock Issued In Relation To Acquisition CommonStockIssuedInRelationToAcquisition	974000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-12555000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13590000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	8319000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	85000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	565000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	277000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	23000	usd
	vrme	Stock Issued During Period Value Common Stock Issued In Relation To Public Offering Of Securities StockIssuedDuringPeriodValueCommonStockIssuedInRelationToPublicOfferingOfSecurities	8447000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	228000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2573000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	14915000	usd
	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice	7.20
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21167000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	139000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	477000	usd
	vrme	Stock Purchase Plan1 StockPurchasePlan1	67000	usd
	vrme	Stock Issued During Period Value Common Stock Issued In Relation To Stock Purchase Plan StockIssuedDuringPeriodValueCommonStockIssuedInRelationToStockPurchasePlan	67000	usd
	vrme	Common Stock Issued In Relation To Private Placement CommonStockIssuedInRelationToPrivatePlacement	4552000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	96000	usd
	vrme	Common Stock Issued In Relation To Acquisition CommonStockIssuedInRelationToAcquisition	974000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13949000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13590000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Reclassifications Reclassifications	<p id="xdx_843_eus-gaap--Reclassifications_zaLNspss3Naf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_86C_z15YldLd3vx3">Reclassifications</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain amounts presented for the three and six months ended June 30, 2021, reflect reclassifications made to conform to the presentation in our current reporting period. </p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zoUkfzIIDLf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_86F_zmNPOuHv1E5i">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p>
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5596000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5596000	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4338000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4338000	shares
CY2022Q2	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	0	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	11000000.0	usd
	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	10964000	usd
CY2022Q2	vrme	Assets1 Assets1	108403000	usd
CY2021Q4	vrme	Assets1 Assets1	109043000	usd
CY2022Q2	vrme	Liabilities Current1 LiabilitiesCurrent1	23000	usd
CY2021Q4	vrme	Liabilities Current1 LiabilitiesCurrent1	3730000	usd
CY2022Q2	vrme	Mezzanine Equity And Stockholders Deficit MezzanineEquityAndStockholdersDeficit	108380000	usd
CY2021Q4	vrme	Mezzanine Equity And Stockholders Deficit MezzanineEquityAndStockholdersDeficit	105313000	usd
CY2022Q2	vrme	Equity Investments Fair Value EquityInvestmentsFairValue	48000	usd
	vrme	Equity Investments Fair Value EquityInvestmentsFairValue	6000	usd
CY2022Q2	vrme	Equity Investments Fair Value1 EquityInvestmentsFairValue1	94000	usd
CY2021Q4	vrme	Equity Investments Fair Value1 EquityInvestmentsFairValue1	88000	usd
CY2022Q2	vrme	Revenue Revenue	4497000	usd
CY2021Q2	vrme	Revenue Revenue	124000	usd
	vrme	Revenue Revenue	4658000	usd
	vrme	Revenue Revenue	312000	usd
CY2022Q2	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	7500000	usd
CY2022Q2	vrme	Business Combination Consideration Transferred2 BusinessCombinationConsiderationTransferred2	10474000	usd
	vrme	Schedule Of Financial Information ScheduleOfFinancialInformation	<p id="xdx_89B_ecustom--ScheduleOfFinancialInformation_zYNZVucPYfX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8B1_zDs6tVzQHbzd">The below table summarizes proforma financial information for the Company, and the acquired PeriShip business, assuming the acquisition date of Periship occurred on January 1, 2021 (dollars in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; text-align: center"> </td> <td id="xdx_498_20220401__20220630_z2N3WagQy22d" style="white-space: nowrap; font-weight: bold; text-align: center"> </td> <td style="white-space: nowrap; font-weight: bold; text-align: center"> </td> <td style="white-space: nowrap; font-weight: bold; text-align: center"> </td> <td style="white-space: nowrap; font-weight: bold; text-align: center"> </td> <td id="xdx_497_20210401__20210630_z1aAadJEqnii" style="white-space: nowrap; font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; text-align: center"> </td> <td id="xdx_497_20220101__20220630_zbQ4VNwxj2ba" style="white-space: nowrap; font-weight: bold; text-align: center"> </td> <td style="white-space: nowrap; font-weight: bold; text-align: center"> </td> <td style="white-space: nowrap; font-weight: bold; text-align: center"> </td> <td style="white-space: nowrap; font-weight: bold; text-align: center"> </td> <td id="xdx_496_20210101__20210630_zit4e93Zc4f" style="white-space: nowrap; font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">Three Months Ended<br/> June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">Six Months Ended<br/> June 30,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; white-space: nowrap"><span style="text-decoration: underline">Description</span></td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr id="xdx_407_ecustom--Revenue1_pn3n3_zlm8UI8DvX8a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Revenues</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,343</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">4,806</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">10,479</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">12,178</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--NetIncomeLoss1_pn3n3_zxuawNr1ZRh8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(12,499</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(456</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(13,847</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,457</td><td style="white-space: nowrap; text-align: left">)</td></tr> </table>
CY2022Q2	vrme	Revenue1 Revenue1	5343000	usd
CY2021Q2	vrme	Revenue1 Revenue1	4806000	usd
	vrme	Revenue1 Revenue1	10479000	usd
	vrme	Revenue1 Revenue1	12178000	usd
CY2022Q2	vrme	Net Income Loss1 NetIncomeLoss1	-12499000	usd
CY2021Q2	vrme	Net Income Loss1 NetIncomeLoss1	-456000	usd
	vrme	Net Income Loss1 NetIncomeLoss1	-13847000	usd
	vrme	Net Income Loss1 NetIncomeLoss1	-1457000	usd
	us-gaap	Acquisition Costs AcquisitionCosts	4092000	usd
CY2022Q2	vrme	Book Value BookValue	4092000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7118000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-601000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6517000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	913000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-404000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	509000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	197000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	29000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	458000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	881000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	869000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	843000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	833000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2633000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6517000	usd
CY2022Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	34000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	173000	usd
CY2021Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	407000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	622000	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	305473	shares
CY2022Q2	vrme	Restricted Common Stock RestrictedCommonStock	194044	shares
CY2021Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	5000	shares
CY2021Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	21	usd
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	198956	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	223956	shares
CY2022Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	756000	usd
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	838000	usd
CY2022Q1	vrme	Nonqualified Stock Purchase Plan NonqualifiedStockPurchasePlan	25000	shares
CY2022Q1	vrme	Nonqualified Stock Purchase Exercise Price NonqualifiedStockPurchaseExercisePrice	2.69
CY2020Q4	us-gaap	Accelerated Share Repurchases Adjustment To Recorded Amount AcceleratedShareRepurchasesAdjustmentToRecordedAmount	1500000	usd
CY2022Q2	vrme	Unrecognized Compensation Cost Outstanding UnrecognizedCompensationCostOutstanding	0	usd
CY2022Q2	vrme	Unrecognized Compensation Cost UnrecognizedCompensationCost	67000	usd
CY2022Q2	vrme	Unrecognized Compensation Cost1 UnrecognizedCompensationCost1	375000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3779243	shares
CY2021Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	5.89
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	1590150	shares
	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice	3.14
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	101679	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	5267714	shares
CY2022Q2	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	5.03
CY2022Q2	vrme	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	3712506	shares
CY2022Q2	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	5.79
	us-gaap	Gross Profit GrossProfit	1808000	usd
	us-gaap	Gross Profit GrossProfit	243000	usd
CY2022Q2	vrme	General And Administrative Expense1 GeneralAndAdministrativeExpense1	2535000	usd
CY2021Q2	vrme	General And Administrative Expense1 GeneralAndAdministrativeExpense1	1217000	usd
	vrme	General And Administrative Expense1 GeneralAndAdministrativeExpense1	4000000	usd
	vrme	General And Administrative Expense1 GeneralAndAdministrativeExpense1	2325000	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	500000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	1500000	usd
CY2022Q2	vrme	Effective Income Tax Rate EffectiveIncomeTaxRate	0.21	pure
CY2022Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	6180000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	4092000	usd
CY2022Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	71000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	21000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	21000	usd
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3000	usd
CY2021Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	6000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	24000	usd
CY2021Q2	us-gaap	Lease Cost LeaseCost	2000	usd
	us-gaap	Lease Cost LeaseCost	28000	usd
	us-gaap	Lease Cost LeaseCost	6000	usd
CY2022Q2	vrme	Research And Development Expense1 ResearchAndDevelopmentExpense1	25000	usd
CY2021Q2	vrme	Research And Development Expense1 ResearchAndDevelopmentExpense1	12000	usd
	vrme	Research And Development Expense1 ResearchAndDevelopmentExpense1	34000	usd
	vrme	Research And Development Expense1 ResearchAndDevelopmentExpense1	17000	usd
CY2022Q2	us-gaap	Revenues Revenues	4497000	usd
CY2021Q2	us-gaap	Revenues Revenues	124000	usd
	us-gaap	Revenues Revenues	4658000	usd
	us-gaap	Revenues Revenues	312000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1685000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	531000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	116000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	416000	usd
CY2022Q2	vrme	Total Operating Lease Liabilities TotalOperatingLeaseLiabilities	532000	usd
CY2022Q2	vrme	Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities	20000	usd
CY2022Q2	vrme	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities	552000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2021Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear	60000	usd
CY2021Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Rolling Twelve Months SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextRollingTwelveMonths	122000	usd
CY2021Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Lease Payments To Be Received Rolling Year Two SalesTypeAndDirectFinancingLeasesLeaseReceivableLeasePaymentsToBeReceivedRollingYearTwo	126000	usd
CY2021Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Lease Payments To Be Received Rolling Year Three SalesTypeAndDirectFinancingLeasesLeaseReceivableLeasePaymentsToBeReceivedRollingYearThree	130000	usd
CY2021Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Rolling Year Four SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRollingYearFour	134000	usd
CY2021Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Lease Payments To Be Received Rolling Year Five SalesTypeAndDirectFinancingLeasesLeaseReceivableLeasePaymentsToBeReceivedRollingYearFive	45000	usd
CY2021Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	617000	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	85000	usd
CY2021Q4	us-gaap	Present Value Of Future Minimum Lease Payments Sale Leaseback Transactions PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions	532000	usd
CY2021Q4	vrme	Finance Lease Liability Current1 FinanceLeaseLiabilityCurrent1	-116000	usd
CY2021Q4	vrme	Finance Lease Liability Noncurrent1 FinanceLeaseLiabilityNoncurrent1	416000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	98000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	447000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	297000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	746000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	544000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1322000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1428000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2972000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2643000	usd
CY2022Q2	vrme	Nonoperating Income Expense1 NonoperatingIncomeExpense1	-11233000	usd
CY2021Q2	vrme	Nonoperating Income Expense1 NonoperatingIncomeExpense1	70000	usd
	vrme	Nonoperating Income Expense1 NonoperatingIncomeExpense1	-10977000	usd
	vrme	Nonoperating Income Expense1 NonoperatingIncomeExpense1	70000	usd
CY2022Q2	vrme	Net Income Loss2 NetIncomeLoss2	-12555000	usd
CY2021Q2	vrme	Net Income Loss2 NetIncomeLoss2	-1358000	usd
	vrme	Net Income Loss2 NetIncomeLoss2	-13949000	usd
	vrme	Net Income Loss2 NetIncomeLoss2	-2573000	usd

Files In Submission

Name	View Source	Status
0001214659-22-010219-index-headers.html	Edgar Link	pending
0001214659-22-010219-index.html	Edgar Link	pending
0001214659-22-010219.txt	Edgar Link	pending
0001214659-22-010219-xbrl.zip	Edgar Link	pending
ex10_14.htm	Edgar Link	pending
ex10_15.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vm72022010q.htm	Edgar Link	pending
vrme-20220630.xsd	Edgar Link	pending
vrme-20220630_cal.xml	Edgar Link	unprocessable
vrme-20220630_lab.xml	Edgar Link	unprocessable
vrme-20220630_pre.xml	Edgar Link	unprocessable
vm72022010q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
vrme-20220630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRME
VerifyMe Inc Stock $vrme

2022 Q3 Form 10-Q Financial Statement

#000121465922010219 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRME VerifyMe Inc Stock $vrme

2022 Q3 Form 10-Q Financial Statement

#000121465922010219 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRME
VerifyMe Inc Stock $vrme